To access this element change to forms mode OFF
Grant Award View - GA58869
Targeting the cancer epigenome to augment anti-tumour immunity
GA ID:
GA58869
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
30-Sep-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2024
Value (AUD):
$639,750.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Targeting the cancer epigenome to augment anti-tumour immunity
Purpose:
Cancer is a disease of the genes. One strategy to stop cancer is by blocking steps on the path from gene to protein, one such process is called 'splicing'. In this project, I will investigate whether disruption of splicing also promotes the body's immune system to attack cancer and whether I can harness this as an effective anti-cancer treatment.
GO ID:
GO Title:
Investigator Grants 2019
Internal Reference ID:
GNT1178338
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES